270 related articles for article (PubMed ID: 29206626)
1. Intensive smoking diminishes the differences in quality of life and exacerbation frequency between the alpha-1-antitrypsin deficiency genotypes PiZZ and PiSZ.
Bernhard N; Lepper PM; Vogelmeier C; Seibert M; Wagenpfeil S; Bals R; Fähndrich S
Respir Med; 2017 Sep; 130():1-8. PubMed ID: 29206626
[TBL] [Abstract][Full Text] [Related]
2. Exacerbations and duration of smoking abstinence are associated with the annual loss of FEV
Fähndrich S; Bernhard N; Lepper PM; Vogelmeier C; Seibert M; Wagenpfeil S; Bals R
Respir Med; 2017 Aug; 129():8-15. PubMed ID: 28732839
[TBL] [Abstract][Full Text] [Related]
3. Deterioration of quality of life is associated with the exacerbation frequency in individuals with alpha-1-antitrypsin deficiency - analysis from the German Registry.
Bernhard N; Lepper PM; Vogelmeier C; Seibert M; Wagenpfeil S; Bals R; Fähndrich S
Int J Chron Obstruct Pulmon Dis; 2017; 12():1427-1437. PubMed ID: 28553095
[TBL] [Abstract][Full Text] [Related]
4. Health status and lung function in the Swedish alpha 1-antitrypsin deficient cohort, identified by neonatal screening, at the age of 37-40 years.
Piitulainen E; Mostafavi B; Tanash HA
Int J Chron Obstruct Pulmon Dis; 2017; 12():495-500. PubMed ID: 28203073
[TBL] [Abstract][Full Text] [Related]
5. PiSZ alpha-1 antitrypsin deficiency (AATD): pulmonary phenotype and prognosis relative to PiZZ AATD and PiMM COPD.
Green CE; Vayalapra S; Hampson JA; Mukherjee D; Stockley RA; Turner AM
Thorax; 2015 Oct; 70(10):939-45. PubMed ID: 26141072
[TBL] [Abstract][Full Text] [Related]
6. Lung function and CT lung densitometry in 37- to 39-year-old individuals with alpha-1-antitrypsin deficiency.
Mostafavi B; Diaz S; Piitulainen E; Stoel BC; Wollmer P; Tanash HA
Int J Chron Obstruct Pulmon Dis; 2018; 13():3689-3698. PubMed ID: 30510411
[TBL] [Abstract][Full Text] [Related]
7. The Swedish α1-Antitrypsin Screening Study: Health Status and Lung and Liver Function at Age 34.
Tanash HA; Nystedt-Düzakin M; Montero LC; Sveger T; Piitulainen E
Ann Am Thorac Soc; 2015 Jun; 12(6):807-12. PubMed ID: 25803183
[TBL] [Abstract][Full Text] [Related]
8. CT scan appearance, densitometry, and health status in protease inhibitor SZ alpha1-antitrypsin deficiency.
Holme J; Stockley RA
Chest; 2009 Nov; 136(5):1284-1290. PubMed ID: 19892672
[TBL] [Abstract][Full Text] [Related]
9. Lung Function and CT Densitometry in Subjects with alpha-1-Antitrypsin Deficiency and Healthy Controls at 35 Years of Age.
Piitulainen E; Montero LC; Nystedt-Düzakin M; Stoel BC; Sveger T; Wollmer P; Tanash HA; Diaz S
COPD; 2015 Apr; 12(2):162-7. PubMed ID: 25280185
[TBL] [Abstract][Full Text] [Related]
10. CT lung densitometry in young adults with alpha-1-antitrypsin deficiency.
Bernspång E; Diaz S; Stoel B; Wollmer P; Sveger T; Piitulainen E
Respir Med; 2011 Jan; 105(1):74-9. PubMed ID: 20674322
[TBL] [Abstract][Full Text] [Related]
11. Decline in FEV
Hiller AM; Piitulainen E; Jehpsson L; Tanash H
Int J Chron Obstruct Pulmon Dis; 2019; 14():1075-1083. PubMed ID: 31213789
[No Abstract] [Full Text] [Related]
12. Lung function in 30-year-old alpha-1-antitrypsin-deficient individuals.
Bernspång E; Wollmer P; Sveger T; Piitulainen E
Respir Med; 2009 Jun; 103(6):861-5. PubMed ID: 19181511
[TBL] [Abstract][Full Text] [Related]
13. Survival in individuals with severe alpha 1-antitrypsin deficiency (PiZZ) in comparison to a general population with known smoking habits.
Tanash HA; Ekström M; Rönmark E; Lindberg A; Piitulainen E
Eur Respir J; 2017 Sep; 50(3):. PubMed ID: 28889108
[TBL] [Abstract][Full Text] [Related]
14. Spanish Registry of Patients With Alpha-1 Antitrypsin Deficiency; Comparison of the Characteristics of PISZ and PIZZ Individuals.
Lara B; Miravitlles M
COPD; 2015 May; 12 Suppl 1():27-31. PubMed ID: 25938288
[TBL] [Abstract][Full Text] [Related]
15. Long-term evolution of lung function in individuals with alpha-1 antitrypsin deficiency from the Spanish registry (REDAAT).
Esquinas C; Serreri S; Barrecheguren M; Rodriguez E; Nuñez A; Casas-Maldonado F; Blanco I; Pirina P; Lara B; Miravitlles M
Int J Chron Obstruct Pulmon Dis; 2018; 13():1001-1007. PubMed ID: 29615836
[TBL] [Abstract][Full Text] [Related]
16. Survival in the Swedish cohort with alpha-1-antitrypsin deficiency, up to the age of 43-45 years.
Mostafavi B; Piitulainen E; Tanash HA
Int J Chron Obstruct Pulmon Dis; 2019; 14():525-530. PubMed ID: 30880942
[TBL] [Abstract][Full Text] [Related]
17. Lung Function and Health Status in Individuals with Severe Alpha-1-Antitrypsin Deficiency at the Age of 42.
Schramm GR; Mostafavi B; Piitulainen E; Wollmer P; Tanash HA
Int J Chron Obstruct Pulmon Dis; 2021; 16():3477-3485. PubMed ID: 34992356
[TBL] [Abstract][Full Text] [Related]
18. Decline in FEV1 related to smoking status in individuals with severe alpha1-antitrypsin deficiency (PiZZ).
Piitulainen E; Eriksson S
Eur Respir J; 1999 Feb; 13(2):247-51. PubMed ID: 10065663
[TBL] [Abstract][Full Text] [Related]
19. Liver function in alpha-1-antitrypsin deficient individuals at 37 to 40 years of age.
Mostafavi B; Diaz S; Tanash HA; Piitulainen E
Medicine (Baltimore); 2017 Mar; 96(12):e6180. PubMed ID: 28328804
[TBL] [Abstract][Full Text] [Related]
20. ICS Use May Modify FEV1 Decline in α1-Antitrypsin Deficiency Patients with Relatively High Blood Eosinophils.
Low EV; Hughes SM; Zaffarullah S; Kantas D; Stockley RA; Turner AM
Respiration; 2018; 95(2):114-121. PubMed ID: 29253843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
